AU2003269254A1 - Treatment of vascular diseases - Google Patents

Treatment of vascular diseases

Info

Publication number
AU2003269254A1
AU2003269254A1 AU2003269254A AU2003269254A AU2003269254A1 AU 2003269254 A1 AU2003269254 A1 AU 2003269254A1 AU 2003269254 A AU2003269254 A AU 2003269254A AU 2003269254 A AU2003269254 A AU 2003269254A AU 2003269254 A1 AU2003269254 A1 AU 2003269254A1
Authority
AU
Australia
Prior art keywords
treatment
vascular diseases
vascular
diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2003269254A
Inventor
Jonathan M. Gibbins
Gwenda J. Graham
Philip J. Lowry
Nigel M. Page
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Reading
Original Assignee
University of Reading
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Reading filed Critical University of Reading
Publication of AU2003269254A1 publication Critical patent/AU2003269254A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/39—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin, cold insoluble globulin [CIG]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482—Serine endopeptidases (3.4.21)
    • A61K38/4833—Thrombin (3.4.21.5)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Urology & Nephrology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
AU2003269254A 2002-10-04 2003-10-06 Treatment of vascular diseases Abandoned AU2003269254A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0223077.9 2002-10-04
GB0223077A GB0223077D0 (en) 2002-10-04 2002-10-04 Treatment of vascular diseases
PCT/GB2003/004335 WO2004030695A1 (en) 2002-10-04 2003-10-06 Treatment of vascular diseases

Publications (1)

Publication Number Publication Date
AU2003269254A1 true AU2003269254A1 (en) 2004-04-23

Family

ID=9945340

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2003269254A Abandoned AU2003269254A1 (en) 2002-10-04 2003-10-06 Treatment of vascular diseases

Country Status (3)

Country Link
AU (1) AU2003269254A1 (en)
GB (1) GB0223077D0 (en)
WO (1) WO2004030695A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420297A (en) * 1990-10-24 1995-05-30 Fujisawa Pharmaceutical Co., Ltd. Peptides having substance P antagonistic activity
AU2001292320A1 (en) * 2000-10-02 2002-04-15 Tanabe Seiyaku Co., Ltd. Benzylamine compound, process for producing the same, and intermediate therefor

Also Published As

Publication number Publication date
GB0223077D0 (en) 2002-11-13
WO2004030695A1 (en) 2004-04-15

Similar Documents

Publication Publication Date Title
AU2002332430A1 (en) Methods of treating neuropilin-mediated diseases
WO2003072035A8 (en) Compositions and methods for the treatment of immune related diseases
WO2004041170A9 (en) Compositions and methods for the treatment of immune related diseases
AU2003290548A1 (en) Prevention and treatment of synucleinopathic disease
EP1480658A4 (en) Methods of treating vascular disease
WO2004024097A9 (en) Compositions and methods for the treatment of immune related diseases
AU2002257936A1 (en) Methods of well treatment
ZA200707934B (en) Thereapeutic formulations for the treatment of beta-amyloid related diseases
HK1083062A1 (en) Treatment of diseases and conditions mediated by increased phosphorylation
AU2003291536A1 (en) Method for the diagnosis and treatment of vascular disease
AU2003217971A1 (en) Gas-plasma treatment of implants
AU2003268923A1 (en) Treatment of aml
AU2003259833A1 (en) Methods of treating neurodegenerative diseases
WO2004024076A8 (en) Novel compositions and methods for the treatment of immune related diseases
AU2002243778A1 (en) Treatment of ppar mediated diseases
AU2003256447A1 (en) Treatment of autoimmune skin diseases
AU2003219580A1 (en) Novel therapeutical use of byakangelicin
AU2003213898A1 (en) Prevention and treatment of mycoplasma-associated diseases
AU2003222250A1 (en) Treatment of autoimmune diseases
AU2003270540A1 (en) Treatment of cyclooxygenase-3 mediated diseases and disorders
AU1405001A (en) Treatment of diseases
AU2003269254A1 (en) Treatment of vascular diseases
AU2003297570A1 (en) Treatment of skin diseases
AU2003238227A1 (en) Treatment of blood with light
AU2002951913A0 (en) Method of treatment

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase